Amber L. Southwell

4.6k total citations
48 papers, 3.2k citations indexed

About

Amber L. Southwell is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Amber L. Southwell has authored 48 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 43 papers in Cellular and Molecular Neuroscience and 10 papers in Neurology. Recurrent topics in Amber L. Southwell's work include Genetic Neurodegenerative Diseases (42 papers), Mitochondrial Function and Pathology (29 papers) and Muscle Physiology and Disorders (17 papers). Amber L. Southwell is often cited by papers focused on Genetic Neurodegenerative Diseases (42 papers), Mitochondrial Function and Pathology (29 papers) and Muscle Physiology and Disorders (17 papers). Amber L. Southwell collaborates with scholars based in Canada, United States and Singapore. Amber L. Southwell's co-authors include Paul H. Patterson, Michael R. Hayden, Niels H. Skotte, Tinh N. Luong, Holly J. Carlisle, Crystal N. Doty, C. Frank Bennett, Jan Ko, Yuanyun Xie and Xinzhong Dong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Amber L. Southwell

47 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amber L. Southwell Canada	31	2.3k	2.0k	687	310	200	48	3.2k
Vikram G. Shakkottai United States	29	2.2k 1.0×	2.0k 1.0×	665 1.0×	368 1.2×	240 1.2×	68	3.1k
Lesley Jones United Kingdom	36	2.3k 1.0×	1.8k 0.9×	698 1.0×	340 1.1×	290 1.4×	79	3.3k
Kinya Ishikawa Japan	34	2.0k 0.9×	1.6k 0.8×	724 1.1×	222 0.7×	197 1.0×	125	3.0k
Ignacio Muñoz-Sanjuán United States	29	2.4k 1.0×	1.2k 0.6×	470 0.7×	208 0.7×	275 1.4×	82	3.3k
Toni Schneider Germany	38	3.4k 1.5×	2.5k 1.2×	436 0.6×	375 1.2×	195 1.0×	139	4.6k
Anne‐Laurence Boutillier France	29	1.5k 0.7×	762 0.4×	383 0.6×	396 1.3×	330 1.6×	54	2.7k
Juan José Toledo‐Aral Spain	26	2.1k 0.9×	1.2k 0.6×	395 0.6×	479 1.5×	432 2.2×	50	3.3k
Nicholas W. Plummer United States	26	1.4k 0.6×	1.1k 0.6×	562 0.8×	163 0.5×	218 1.1×	41	2.7k
Paymaan Jafar‐Nejad United States	23	1.6k 0.7×	920 0.5×	610 0.9×	243 0.8×	320 1.6×	55	2.3k
Jack Puymirat Canada	36	2.4k 1.0×	1.7k 0.8×	414 0.6×	235 0.8×	627 3.1×	123	3.8k

Countries citing papers authored by Amber L. Southwell

Since Specialization

Citations

This map shows the geographic impact of Amber L. Southwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amber L. Southwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amber L. Southwell more than expected).

Fields of papers citing papers by Amber L. Southwell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amber L. Southwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amber L. Southwell. The network helps show where Amber L. Southwell may publish in the future.

Co-authorship network of co-authors of Amber L. Southwell

This figure shows the co-authorship network connecting the top 25 collaborators of Amber L. Southwell. A scholar is included among the top collaborators of Amber L. Southwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amber L. Southwell. Amber L. Southwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Harding, Rachel, Yuanyun Xie, Nicholas S. Caron, et al.. (2025). Challenges and advances for huntingtin detection in cerebrospinal fluid: in support of relative quantification. Biomarker Research. 13(1). 63–63.

Bartl, Stefan, Yuanyun Xie, Nalini Potluri, et al.. (2023). Reducing huntingtin by immunotherapy delays disease progression in a mouse model of Huntington disease. Neurobiology of Disease. 190. 106376–106376. 2 indexed citations

Caron, Nicholas S., Amirah E.-E. Aly, Yuanyun Xie, et al.. (2022). Cerebrospinal fluid mutant huntingtin is a biomarker for huntingtin lowering in the striatum of Huntington disease mice. Neurobiology of Disease. 166. 105652–105652. 15 indexed citations

Caron, Nicholas S., Christopher Yanick, Amirah E.-E. Aly, et al.. (2020). Mutant Huntingtin Is Cleared from the Brain via Active Mechanisms in Huntington Disease. Journal of Neuroscience. 41(4). 780–796. 46 indexed citations

Bedwell, Jeffrey S., Christopher Spencer, & Amber L. Southwell. (2020). Childhood Cat Bites Relate to Increased Adulthood Severity of Schizotypy, Psychotic-Like Experiences, and Social Anhedonia in a Transdiagnostic Psychiatric Sample. Psychopathology. 53(1). 36–47. 4 indexed citations

Sanders, Shaun S., Matthew P. Parsons, Amber L. Southwell, et al.. (2016). Sudden death due to paralysis and synaptic and behavioral deficits when Hip14/Zdhhc17 is deleted in adult mice. BMC Biology. 14(1). 108–108. 22 indexed citations

Connolly, Colúm, Guihua Lu, Amber L. Southwell, et al.. (2016). Enhanced immune response to MMP3 stimulation in microglia expressing mutant huntingtin. Neuroscience. 325. 74–88. 34 indexed citations

Southwell, Amber L., Stephen Smith, Nicholas S. Caron, et al.. (2015). Ultrasensitive measurement of huntingtin protein in cerebrospinal fluid demonstrates increase with Huntington disease stage and decrease following brain huntingtin suppression. Scientific Reports. 5(1). 12166–12166. 78 indexed citations

Skotte, Niels H., Amber L. Southwell, Michael E. Østergaard, et al.. (2014). Allele-Specific Suppression of Mutant Huntingtin Using Antisense Oligonucleotides: Providing a Therapeutic Option for All Huntington Disease Patients. PLoS ONE. 9(9). e107434–e107434. 85 indexed citations

10.

Kołodziejczyk, Karolina, Matthew P. Parsons, Amber L. Southwell, Michael R. Hayden, & Lynn A. Raymond. (2014). Striatal Synaptic Dysfunction and Hippocampal Plasticity Deficits in the Hu97/18 Mouse Model of Huntington Disease. PLoS ONE. 9(4). e94562–e94562. 33 indexed citations

11.

Southwell, Amber L., Niels H. Skotte, Holly Kordasiewicz, et al.. (2014). In Vivo Evaluation of Candidate Allele-specific Mutant Huntingtin Gene Silencing Antisense Oligonucleotides. Molecular Therapy. 22(12). 2093–2106. 107 indexed citations

12.

Parsons, Matthew P., Rujun Kang, Amber L. Southwell, et al.. (2013). Bidirectional Control of Postsynaptic Density-95 (PSD-95) Clustering by Huntingtin. Journal of Biological Chemistry. 289(6). 3518–3528. 32 indexed citations

13.

Southwell, Amber L., et al.. (2012). Age-Dependent Resistance to Excitotoxicity in Htt CAG140 Mice and the Effect of Strain Background. Journal of Huntington s Disease. 1(2). 221–241. 11 indexed citations

14.

Pouladi, Mahmoud A., Lisa M. Stanek, Yuanyun Xie, et al.. (2012). Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice. Human Molecular Genetics. 21(10). 2219–2232. 115 indexed citations

15.

Southwell, Amber L., Niels H. Skotte, C. Frank Bennett, & Michael R. Hayden. (2012). Antisense oligonucleotide therapeutics for inherited neurodegenerative diseases. Trends in Molecular Medicine. 18(11). 634–643. 102 indexed citations

16.

Luong, Tinh N., Holly J. Carlisle, Amber L. Southwell, & Paul H. Patterson. (2011). Assessment of Motor Balance and Coordination in Mice using the Balance Beam. Journal of Visualized Experiments. 297 indexed citations

17.

Carroll, Jeffrey B., Simon C. Warby, Amber L. Southwell, et al.. (2011). Potent and Selective Antisense Oligonucleotides Targeting Single-Nucleotide Polymorphisms in the Huntington Disease Gene / Allele-Specific Silencing of Mutant Huntingtin. Molecular Therapy. 19(12). 2178–2185. 225 indexed citations

18.

Southwell, Amber L. & Paul H. Patterson. (2011). Gene Therapy in Mouse Models of Huntington Disease. The Neuroscientist. 17(2). 153–162. 17 indexed citations

19.

Southwell, Amber L., et al.. (2008). Intrabodies Binding the Proline-Rich Domains of Mutant Huntingtin Increase Its Turnover and Reduce Neurotoxicity. Journal of Neuroscience. 28(36). 9013–9020. 95 indexed citations

20.

Chiu, Chi‐Sung, Stephen G. Brickley, Kimmo Jensen, et al.. (2005). GABA Transporter Deficiency Causes Tremor, Ataxia, Nervousness, and Increased GABA-Induced Tonic Conductance in Cerebellum. Journal of Neuroscience. 25(12). 3234–3245. 196 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact